Normally, when the Fed starts loosening policy it does so amid clear-cut signs of economic weakness.Economyread more
Wall Street economists are anxiously awaiting Wednesday's FOMC meeting.Marketsread more
With bold and targeted steps, economists say, government can increase opportunity and incomes for many more people in ways that strengthen, not weaken, American capitalism.Politicsread more
CNBC's Jim Cramer connects the dots by reasoning that if the president were to act he would pick a replacement for Powell that would do his bidding.Economyread more
Shoppers are "very nuanced in their expectations," Ron Johnson, the former CEO of J.C. Penney and the former senior vice president of Apple's retail division, said at CNBC's...Evolveread more
We've been given plenty of reasons to quit Facebook, including a new report that alleges disgusting working conditions at a company, Cognizant, it uses to employ contractors....Technologyread more
This just might be Fed Chair Jerome Powell's toughest meeting yet, because whatever the outcome, odds are high that it will disappoint a large group.Market Insiderread more
More and more American firms are calling for the Trump administration to resolve its conflict with China.World Economyread more
Facebook is leading the FANG stocks this year, and Miller Tabak's Matt Maley foresees more upside.Trading Nationread more
All trains traveling in and out of New York Penn Station have been halted because of an Amtrak overhead wire issue, New Jersey Transit said Wednesday.Transportationread more
American Airlines is the first major U.S. airline to order Airbus' new long-range, single aisle aircraft.Paris Air Showread more
Wentworth, who runs one of the largest pharmacy benefits management organizations -- otherwise known as PBMs -- appears to have contemplated this question quite a bit.
"So as I think about Amazon and what they may choose to do in pharmacy, you said it right in the beginning, which is, you know, becoming a PBM is a lot more than dispensing drugs," he responded to an analyst.
PBMs act as intermediaries between payers, like health insurers, and the rest of the health system.
Speculation has ensued for months that the company will attempt to disrupt PBMs like Express Scripts, and bring some transparency to drug pricing. CNBC reported in May that Amazon has a secret health team and is hiring experts to help steer it into the multibillion-dollar pharmacy market.
All of this puts Express Scripts in a tricky spot.
Wentworth suggested that the company would be open to working with Amazon rather than competing with them. "If Amazon were looking to be an efficient provider in networks, we would welcome that opportunity," Wentworth told analysts on the call.
Some experts find this move to be somewhat surprising.
"Typically there is only 1 mail order pharmacy in a PBM and it's the one owned by the PBM," said Adam Fein, president of Pembroke Consulting and author of Drug Channels. "It's unusual for them to signal this."
It's still early days for Amazon, and the company hasn't announced anything official. The company might prioritize other areas first, said Fein. As CNBC reported this week, the company is also interested in other areas like telemedicine and electronic medical records.
"Amazon has a long way to go before it becomes a mail order pharmacy," said Fein, who pointed to myriad challenges ahead ranging from regulatory to technical. And if it were to become a network pharmacy, he said, it would need to build the "back engine" to accept insurance and adjudicate claims.
"I think Amazon has more lucrative areas to go after than becoming a PBM," he said.